Polymorphisms in the MDM2 promoter and risk of breast cancer: a case-control analysis in a Chinese population

Cancer Letters

Volumn 240, Issue 2, 2006, Pages 261-267

  Ma, Hongxia ^a   Hu, Zhibin ^a   Zhai, Xiangjun ^a   Wang, Shui ^a   Wang, Xuechen ^b   Qin, Jianwei ^c   Jin, Guangfu ^a   Liu, Jiyong ^a   Wang, Xinru ^a   Wei, Qingyi ^d   Shen, Hongbing ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

^b THE AFFILIATED DRUM TOWER HOSPITAL OF NANJING UNIVERSITY MEDICAL SCHOOL   (China)

^c JIANGSU CANCER HOSPITAL   (China)

^d UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; Genetic polymorphism; MDM2; Molecular epidemiology

Indexed keywords

PROTEIN MDM2;

ADULT; ARTICLE; BENIGN TUMOR; BREAST ADENOCARCINOMA; CANCER EPIDEMIOLOGY; CANCER PATIENT; CANCER RISK; CHINA; CONFIDENCE INTERVAL; CONTROLLED STUDY; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MOLECULAR GENETICS; MUTATIONAL ANALYSIS; POPULATION BASED CASE CONTROL STUDY; POPULATION RISK; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; SINGLE NUCLEOTIDE POLYMORPHISM; STATISTICAL ANALYSIS;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BREAST DISEASES; CASE-CONTROL STUDIES; CHINA; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROMOTER REGIONS (GENETICS); PROTO-ONCOGENE PROTEINS C-MDM2; RISK FACTORS; SEQUENCE DELETION;

EID: 33746239400     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2005.09.019     Document Type: Article

References (28)

1. Ferlay J., Bray F., Pisane P., and Parkin D.M. Cancer Incidence, Mortality and Prevalence Worldwide (2000), Globocan IARC Press, Lyon
2. Yang L., Parkin D.M., Li L., and Chen Y. Time trends in cancer mortality in China: 1987-1999. Int. J. Cancer 106 (2003) 771-783
3. Wolff M.S., and Weston A. Breast cancer risk and environmental exposures. Environ. Health Perspect. 105 (1997) 891-896
4. Hulka B.S., and Moorman P.G. Breast cancer: hormones and other risk factors. Maturitas 38 (2001) 103-113
5. Levine A.J. p53, the cellular gatekeeper for growth and division. Cell 88 (1997) 323-331
6. Wu L., and Levine A.J. Differential regulation of the p21/WAF-1 and mdm2 genes after high-dose UV irradiation: p53-dependent and p53-independent regulation of the mdm2 gene. Mol. Med. 3 (1997) 441-451
7. Michael D., and Oren M. The p53 and Mdm2 families in cancer. Curr. Opin. Genet. Dev. 12 (2002) 53-59
8. Geyer R.K., Yu Z.K., and Maki C.G. The MDM2 RING-finger domain is required to promote p53 nuclear export. Nat. Cell Biol. 2 (2000) 569-573
9. Roth J., Dobbelstein M., Freedman D.A., Shenk T., and Levine A.J. Nucleo-cytoplasmic shuttling of the hdm2 oncoprotein regulates the levels of the p53 protein via a pathway used by the human immunodeficiency virus rev protein. Eur. Mol. Biol. Org. J. 17 (1998) 554-564
10. Tao W., and Levine A.J. Nucleocytoplasmic shuttling of oncoprotein Hdm2 is required for Hdm2-mediated degradation of p53. Proc. Natl Acad. Sci. USA 96 (1999) 3077-3080
11. Lundgren K., Montes de Oca Luna R., McNeill Y.B., Emerick E.P., Spencer B., Barfield C.R., et al. Targeted expression of MDM2 uncouples S phase from mitosis and inhibits mammary gland development independent of p53. Genes Dev. 11 (1997) 714-725
12. Cordon-Cardo C., Latres E., Drobnjak M., Oliva M.R., Pollack D., Woodruff J.M., et al. Molecular abnormalities of mdm2 and p53 genes in adult soft tissue sarcomas. Cancer Res. 54 (1994) 794-799
13. Bueso-Ramos C.E., Manshouri T., Haidar M.A., Yang Y., McCown P., Ordonez N., et al. Abnormal expression of MDM-2 in breast carcinomas. Breast Cancer Res. Treat. 37 (1996) 179-188
14. Baunoch D., Watkins L., Tewari A., Reece M.L.A., Stack R., Brown A., et al. MDM2 overexpression in benign and malignant lesions of the human breast. Int. J. Oncol. 8 (1996) 895-899
15. Baccouche S., Daoud J., Frikha M., Mokdad-Gargouri R., Gargouri A., and Jlidi R. Immunohistochemical status of p53, MDM2, bcl2, bax, and ER in invasive ductal breast carcinoma in Tunisian patients. Ann. NY Acad. Sci. 1010 (2003) 752-763
16. Jones S.N., Hancock A.R., Vogel H., Donehower L.A., and Bradley A. Overexpression of Mdm2 in mice reveals a p53-independent role for Mdm2 in tumorigenesis. Proc. Natl Acad. Sci. USA 95 (1998) 15608-15612
17. Juven-Gershon T., and Oren M. Mdm2: the ups and downs. Mol. Med. 5 (1999) 71-83
18. Lain S., and Lane D. Improving cancer therapy by non-genotoxic activation of p53. Eur. J. Cancer. 39 (2003) 1053-1060
19. Leach F.S., Tokino T., Meltzer P., Burrell M., Oliner J.D., Smith S., et al. p53 Mutation and MDM2 amplification in human soft tissue sarcomas. Cancer Res. 53 (1993) 2231-2234
20. Oliner J.D., Kinzler K.W., Meltzer P.S., George D.L., and Vogelstein B. Amplification of a gene encoding a p53-associated protein in human sarcomas. Nature 358 (1992) 80-83
21. Iwakuma T., and Lozano G. MDM2, an introduction. Mol. Cancer Res. 1 (2003) 993-1000
22. Bond G.L., Hu W., Bond E.E., Robins H., Lutzker S.G., Arva N.C., et al. A single nucleotide polymorphism in the MDM2 promoter attenuates the p53 tumor suppressor pathway and accelerates tumor formation in humans. Cell 119 (2004) 591-602
23. Ke X., Collins A., and Ye S. PIRA PCR designer for restriction analysis of single nucleotide polymorphisms. Bioinformatics 17 (2001) 838-839
24. Daujat S., Neel H., and Piette J. MDM2: life without p53. Trends Genet. 17 (2001) 459-464
25. Martin K., Trouchem D., Hagemeier C., Sorensen T.S., La Thangue N.B., and Kouzarides T. Stimulation of E2F1/DP1 transcriptional activity by MDM2 oncoprotein. Nature 375 (1995) 691-694
26. Xiao Z.X., Chen J., Levine A.J., Modjtahedi N., Xing J., Sellers W.R., et al. Interaction between the retinoblastoma protein and the oncoprotein MDM2. Nature 375 (1995) 694-698
27. Gudas J.M., Nguyen H., Klein R.C., Katayose D., Seth P., and Cowan K.H. Differential expression of multiple MDM2 messenger RNAs and proteins in normal and tumorigenic breast epithelial cells. Clin. Cancer Res. 1 (1995) 71-80
28. Maya R., Balass M., Kim S.T., Shkedy D., Leal J.F., Shifman O., et al. ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage. Genes Dev. 15 (2001) 1067-1077